US Patent Issued to GENOIMMUNE THERAPEUTICS on Oct. 28 for "Tumor immunotherapy polypeptide and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,774, issued on Oct. 28, was assigned to GENOIMMUNE THERAPEUTICS Co. LTD. (Wuhan, China).

"Tumor immunotherapy polypeptide and application thereof" was invented by Si Qiu (Hubei, China), Bo Li (Hubei, China), Youping Li (Hubei, China) and Le Zhang (Hubei, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a polypeptide for tumor immunotherapy and use thereof. The polypeptide includes at least one polypeptide in a first peptide group, and optionally, at least one polypeptide in a second peptide group, the first peptide group includes polypeptides having amino acid sequences set forth in SEQ ID NO: 1 to SEQ ID NO: 6, and first derivative...